Latest Strategic Outlook News

Page 6 of 101
Actinogen Medical has successfully completed a $16.8 million capital raising, combining a $12 million placement with a $4.8 million share purchase plan, to fund its pivotal Alzheimer’s disease trial and other 2026 initiatives.
Ada Torres
Ada Torres
27 Feb 2026
Beam Communications has turned around its fortunes, posting a $2 million net profit for the first half of FY26 and announcing a $12.1 million capital return following the divestment of Zoleo Inc.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Hydrix Limited reported a 14% revenue decline and a sharp increase in net loss for H1 2026, raising concerns about its financial stability despite securing a major contract.
Ada Torres
Ada Torres
27 Feb 2026
Matrix Composites & Engineering Ltd reported a $9.4 million loss for the half-year ending December 2025, driven by a 32% drop in revenue to $26.9 million. Despite the weak first half, the company anticipates a robust second half to meet or exceed last year’s full-year revenue.
Victor Sage
Victor Sage
27 Feb 2026
Dataworks Group Limited reported a significant reduction in its half-year loss alongside a major contract extension in Ontario, marking a pivotal shift to positive cash flow.
Sophie Babbage
Sophie Babbage
26 Feb 2026
DorsaVi Limited reported a steep increase in its half-year loss to $3.6 million, driven by declining revenues and a sharp rise in operating costs, despite raising over $5 million in fresh capital.
Victor Sage
Victor Sage
26 Feb 2026
Shriro Holdings reported solid half-year growth with revenue up 8.4% and NPAT rising 10%, underpinned by strong BBQ and kitchen appliance sales. The company reaffirmed its EBITDA guidance and announced a $15 million off-market share buy-back for FY26.
Victor Sage
Victor Sage
26 Feb 2026
Dubber Corporation reported a 9% revenue decline to $18.7 million for the half-year ending December 2025, alongside a 65% reduction in net loss. The company pursues growth through AI innovation and cost efficiencies while navigating ongoing legal proceedings.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Cynata Therapeutics reported a reduced half-year loss alongside progress in pivotal clinical trials, extending its cash runway into mid-2026. Investors await critical data from Phase 3 and Phase 2 studies expected in the coming months.
Ada Torres
Ada Torres
26 Feb 2026
CVC Limited has finalized the unconditional sale of its Laverton property through a joint venture, forecasting a significant profit and strong cash inflow for FY 2026.
Eva Park
Eva Park
26 Feb 2026
Ovanti Limited announces a strategic leadership change in its US operations to boost its BNPL platform Flote’s commercialisation and prepare for a potential NASDAQ listing via SPAC.
Victor Sage
Victor Sage
26 Feb 2026
TZ Limited reported a $1.92 million loss for the half-year ending December 2025, with revenues of $5.4 million impacted by delayed US projects and integration challenges from its Keyvision acquisition. The company is banking on large tenders and expanding Microsoft data centre sales to drive recovery.
Sophie Babbage
Sophie Babbage
26 Feb 2026